Abiopharma

🔍 Peterson Bradley J (Executive)

Company: NASDAQ, INC. (NDAQ)

Report Date: 2026-08-07

Detailed Transactions and Holdings:

• Sold 6,000 shares of Common Stock, par value $0.01 pershare at $95.55 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 122,293.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents (i) 64,377 shares or units of restricted stock, 38,372 of which are vested, (ii) 52,618 shares of Common Stock underlying PSUs, 42,986 of which are vested, and (iii) 5,298 shares of Common Stock purchased under the Issuer's Employee Stock Purchase Plan.